ALCON LABORATORIES, INC. for ALCON LABORATORIES INC
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues concerning the NTIOL program.
Foreign entity interest: From January 1, 2011 to April 7, 2011, Novartis AG, a foreign Swiss entity, was the majority shareholder of Alcon, Inc. On April 8, 2011, Novartis AG became the sole shareholder of Alcon, Inc. and Alcon, Inc. was merged out of corporate existence. Alcon Laboratories, Inc. is a subsidiary of Alcon Holdings, Inc. Alcon Holdings, Inc. was a subsidiary of Alcon, Inc. until April 7, 2011. On April 8, 2011, with the dissolution of Alcon, Inc., Alcon Holdings, Inc. became a subsidiary of Novartis AG.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETTE MCCLELLAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.